TY - JOUR T1 - Stem cells as vectors for antitumour therapy JF - Thorax JO - Thorax SP - 362 LP - 369 DO - 10.1136/thx.2009.128025 VL - 65 IS - 4 AU - Michael R Loebinger AU - Sam M Janes Y1 - 2010/04/01 UR - http://thorax.bmj.com/content/65/4/362.abstract N2 - Recent research suggests that mesenchymal stem cells (MSCs) are able to migrate specifically to tumours and their metastases throughout the body. This has led to considerable excitement about the possibility of modifying these cells to express anticancer molecules and using them as specific targeted anticancer agents. However, there are concerns that systemically delivered MSCs may have non-desirable effects, and there are also many unanswered questions including the mechanism of tumour homing. This review investigates the different MSC-delivered anticancer agents, addresses the questions and concerns, and tries to place this potential therapy in future cancer management. ER -